Results of ENHANCE (Ezetimibe aNd simvastatin in Hypercholesterolemia enhANces atherosClerosis rEgression), an imaging trial in 720 patients with heterozygous familial hypercholesterolemia (HeFH), a rare genetic condition that causes very high levels of LDL "bad" cholesterol and greatly increases
This entry was posted
on Monday, March 31st, 2008 at 7:00 am and is filed under Cholesterol.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
